Santosh Vetticaden - Net Worth and Insider Trading

Santosh Vetticaden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Santosh Vetticaden owns 2 companies in total, including Insys Therapeutics Inc (INSYQ) , and Savara Inc (SVRA) .

Click here to see the complete history of Santosh Vetticaden’s form 4 insider trades.

Insider Ownership Summary of Santosh Vetticaden

Ticker	Comapny	Transaction Date	Type of Owner
INSYQ	Insys Therapeutics Inc	2017-02-21	Interim CEO and CMO
SVRA	Savara Inc	2012-09-05	Chief Medical Officer & SVP

Santosh Vetticaden Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Santosh Vetticaden Ownership Network

Ownership Network List of Santosh Vetticaden

No Data

Ownership Network Relation of Santosh Vetticaden

Santosh Vetticaden Owned Company Details

What does Insys Therapeutics Inc do?

Who are the key executives at Insys Therapeutics Inc?

Santosh Vetticaden is the Interim CEO and CMO of Insys Therapeutics Inc. Other key executives at Insys Therapeutics Inc include director & Chief Executive Officer Andrew G Long , Chief Legal Officer & Gen Cnsl Mark E Nance , and 10 percent owner John N Kapoor .

Insys Therapeutics Inc (INSYQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Insys Therapeutics Inc (INSYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Insys Therapeutics Inc (INSYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Insys Therapeutics Inc (INSYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Insys Therapeutics Inc Insider Transactions

No Available Data

Santosh Vetticaden Mailing Address

Above is the net worth, insider trading, and ownership report for Santosh Vetticaden. You might contact Santosh Vetticaden via mailing address: C/o Adventrx Pharmaceuticals, Inc., 12390 El Camino Real, Suite 150, San Diego Ca 92130.

Discussions on Santosh Vetticaden

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.